Asmaa M AboulMagd
Overview
Explore the profile of Asmaa M AboulMagd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abd El-Mawgoud H, AboulMagd A, Shaker A, Hemdan M, Hassaballah A, Farag P
Bioorg Chem
. 2025 Jan;
155():108101.
PMID: 39809117
The escalating prevalence of antibiotic-resistant bacteria has led to a serious global public health problem; therefore, there is an urgent need for the development of structurally innovative antibacterial agents. In...
2.
Mohie El-Dien R, Maher S, Abdelmohsen U, AboulMagd A, Fouad M, Kamel M
RSC Adv
. 2025 Jan;
15(2):1051.
PMID: 39807199
[This retracts the article DOI: 10.1039/D0RA06104B.].
3.
Abd El-Mawgoud H, AboulMagd A, Nemr M, Hemdan M, Hassaballah A, Farag P
Bioorg Chem
. 2024 Jul;
150:107622.
PMID: 38996545
Novel thieno[2,3-d]pyrimidine analogues were designed, synthesized and evaluated for anti-proliferative activity against HepG-2, PC-3 and MCF-7 cancer cell lines. In addition, WI-38 normal cell line was used to explore the...
4.
Moustafa A, AboulMagd A, Ali A, Khodairy A, Marzouk A, Nafady A, et al.
Bioorg Chem
. 2024 Apr;
147:107410.
PMID: 38688197
A new series of benzene-sulfonamide derivatives 3a-i was designed and synthesized via the reaction of N-(pyrimidin-2-yl)cyanamides 1a-i with sulfamethazine sodium salt 2 as dual Src/Abl inhibitors. Spectral data IR, H-,...
5.
Mansour M, AboulMagd A, Abbas S, Abdel-Aziz M, Abdel-Rahman H
Arch Pharm (Weinheim)
. 2024 Feb;
357(5):e2300626.
PMID: 38297894
Two new series of quinazoline-chalcone hybrids were designed, synthesized as histone deacetylase (HDAC)/epidermal growth factor receptor (EGFR) dual inhibitors, and screened in vitro against the NCI 60 human cancer cell...
6.
Hassaballah A, AboulMagd A, Hemdan M, Hekal M, El-Sayed A, Farag P
RSC Adv
. 2024 Jan;
14(3):1995-2015.
PMID: 38196910
In this study, four series of new pyrazolo[3,4-]pyrimidine derivatives were designed and synthesized with both green and conventional methods. All the synthesized candidates were chemically confirmed using spectroscopic methods, and...
7.
AbdelSamad A, El-Saadi M, Gouda A, AboulMagd A
RSC Adv
. 2023 Oct;
13(44):30753-30770.
PMID: 37869384
Two new series of pyrrolizine/indolizine derivative-bearing (un)substituted isoindole moiety were designed and synthesized. The anticancer potential of the new compounds was evaluated against hepatocellular carcinoma (HepG-2), colorectal carcinoma, colon cancer...
8.
Mansour M, AboulMagd A, Abbas S, Abdel-Rahman H, Abdel-Aziz M
RSC Adv
. 2023 Jun;
13(27):18825-18853.
PMID: 37350862
Lung cancer is the second most common cause of morbidity and mortality among cancer types worldwide, with non-small cell lung cancer (NSCLC) representing the majority of most cases. Epidermal growth...
9.
Mekhlef Y, AboulMagd A, Gouda A
Bioorg Chem
. 2023 Feb;
133:106411.
PMID: 36801792
A new series of 2,3-diaryl-1,3thiazolidin-4-one derivatives was designed, synthesized, and evaluated for their cytotoxicity and COXs inhibitory activities. Among these derivatives, compounds 4 k and 4j exhibited the highest inhibitory...
10.
Farag P, AboulMagd A, Hemdan M, Hassaballah A
Bioorg Chem
. 2022 Nov;
130:106231.
PMID: 36335649
Different series of annulated pyrazole derivatives were designed, synthesized via both green and traditional methods, and structurally characterized. In vitro uPA evaluation, antiproliferative activities and DNA binding damage was studied...